Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

126.78 -0.59 (-0.47%)
Streaming Delayed Price Updated: 12:25 PM EDT, May 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
This Is What Whales Are Betting On DexCom
Via Benzinga
2 Best Healthcare Stocks to Buy Right Now
The healthcare industry is an explosive space full of promising, profitable companies. 
Via The Motley Fool
DexCom's Earnings: A Preview
Via Benzinga
Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027
EQNX::TICKER_START (OTCPK:CNER),(NYSE:NVO),(NASDAQ:TNDM),(NASDAQ:DXCM),(NASDAQ:LXRX) EQNX::TICKER_END 
Via FinancialNewsMedia
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Comparing DexCom With Industry Competitors In Health Care Equipment &amp; Supplies Industry
Via Benzinga
Price Over Earnings Overview: DexCom
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are two high-flying stock-split stocks a pair of analysts believe will lose their... 
Via The Motley Fool
MarketBeat Week in Review – 10/16 - 10/20
All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Economy Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Analyst Expectations for DexCom's Future
Via Benzinga
Looking Into DexCom's Recent Short Interest
Via Benzinga
Why DexCom Stock Rallied on Monday
The medical device maker got a little love from Wall Street. 
Via The Motley Fool
The 7 Best Nasdaq Stocks To Buy Now: October 2023
The best Nasdaq stocks go much deeper than the magnificent 7 and offer surprising stability in addition to broad exposure to AI. 
Via InvestorPlace
3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings
These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year. 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
DexCom Unusual Options Activity
Via Benzinga
Why DexCom (DXCM) Stock Hit A New 52-Week Low Today
DexCom, Inc. (NASDAQ: DXCM) shares are trading lower by 1.58% to $77.73 Thursday afternoon. 
Via Benzinga
2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value
These can be excellent investments to buy and hold for years. 
Via The Motley Fool
Is the Ozempic-Driven DexCom Selloff Overdone?
Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly? 
Via MarketBeat
While growth is established for NASDAQ:DXCM, the stock's valuation remains reasonable.
NASDAQ:DXCM is not too expensive for the growth it is showing. 
Via Chartmill
3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three stock-split stocks select people on Wall Street believe offer... 
Via The Motley Fool
Why DexCom Stock Is Rising During Monday's Session
DexCom, Inc. (NASDAQ: DXCM) shares are trading higher by 3.75% to $79.05 Thursday afternoon. Leerink Partners initiated coverage on the stock with an Outperform rating and a $110 price target. 
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street
Two investor-favorite stock-split stocks still have plenty of room to run. 
Via The Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in October and 1 to Avoid
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one historically cheap stock-split stock, as well as another company that carries... 
Via The Motley Fool
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
From DexCom, Inc.
Via Business Wire
Buy this Tech Stock on the Dip in October for 50% Upside?
DexCom, Inc. is a connected medical device standout that has posted steadily massive YoY growth as more people in the U.S. and globally suffer from diabetes. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.